vs
Encompass Health Corp（EHC）与STIFEL FINANCIAL CORP（SF）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是STIFEL FINANCIAL CORP的1.4倍（$1.5B vs $1.1B），STIFEL FINANCIAL CORP净利率更高（23.5% vs 9.5%，领先14.0%），STIFEL FINANCIAL CORP同比增速更快（23.0% vs 9.9%），STIFEL FINANCIAL CORP自由现金流更多（$369.0M vs $116.7M），过去两年STIFEL FINANCIAL CORP的营收复合增速更高（21.1% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
司迪富金融是美国跨国独立投资银行及金融服务提供商，总部位于密苏里州圣路易斯市中心。其历史可追溯至1890年成立的Altheimer & Rawlings投资公司，1983年正式以Stifel为名成立，1986年11月24日在纽约证券交易所挂牌上市，为全球客户提供多元化金融服务。
EHC vs SF — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.1B |
| 净利润 | $146.1M | $264.4M |
| 毛利率 | — | — |
| 营业利润率 | 16.7% | 27.3% |
| 净利率 | 9.5% | 23.5% |
| 营收同比 | 9.9% | 23.0% |
| 净利润同比 | 20.8% | 8.3% |
| 每股收益（稀释后） | $1.43 | $2.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.5B | $962.6M | ||
| Q2 25 | $1.5B | $838.9M | ||
| Q1 25 | $1.5B | $842.5M | ||
| Q4 24 | $1.4B | $916.0M | ||
| Q3 24 | $1.4B | $810.9M | ||
| Q2 24 | $1.3B | $798.9M | ||
| Q1 24 | $1.3B | $768.1M |
| Q4 25 | $146.1M | $264.4M | ||
| Q3 25 | $126.5M | $211.4M | ||
| Q2 25 | $142.1M | $155.1M | ||
| Q1 25 | $151.5M | $53.0M | ||
| Q4 24 | $120.9M | $244.0M | ||
| Q3 24 | $108.2M | $158.5M | ||
| Q2 24 | $114.1M | $165.3M | ||
| Q1 24 | $112.5M | $163.6M |
| Q4 25 | 16.7% | 27.3% | ||
| Q3 25 | 14.9% | 29.7% | ||
| Q2 25 | 16.2% | 25.5% | ||
| Q1 25 | 16.4% | 7.5% | ||
| Q4 24 | 14.3% | 29.1% | ||
| Q3 24 | 13.6% | 26.7% | ||
| Q2 24 | 14.3% | 28.4% | ||
| Q1 24 | 13.6% | 28.5% |
| Q4 25 | 9.5% | 23.5% | ||
| Q3 25 | 8.6% | 22.0% | ||
| Q2 25 | 9.7% | 18.5% | ||
| Q1 25 | 10.4% | 6.3% | ||
| Q4 24 | 8.6% | 26.6% | ||
| Q3 24 | 8.0% | 19.5% | ||
| Q2 24 | 8.8% | 20.7% | ||
| Q1 24 | 8.5% | 21.3% |
| Q4 25 | $1.43 | $2.30 | ||
| Q3 25 | $1.24 | $1.84 | ||
| Q2 25 | $1.39 | $1.34 | ||
| Q1 25 | $1.48 | $0.39 | ||
| Q4 24 | $1.18 | $2.10 | ||
| Q3 24 | $1.06 | $1.34 | ||
| Q2 24 | $1.12 | $1.41 | ||
| Q1 24 | $1.10 | $1.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $2.3B |
| 总债务越低越好 | $2.4B | $617.4M |
| 股东权益账面价值 | $2.4B | $6.0B |
| 总资产 | $7.1B | $41.3B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.10× |
8季度趋势，按日历期对齐
| Q4 25 | $72.2M | $2.3B | ||
| Q3 25 | $48.7M | $3.2B | ||
| Q2 25 | $99.1M | $1.9B | ||
| Q1 25 | $95.8M | $2.7B | ||
| Q4 24 | $85.4M | $2.6B | ||
| Q3 24 | $147.8M | $1.9B | ||
| Q2 24 | $154.4M | $2.6B | ||
| Q1 24 | $134.4M | $3.4B |
| Q4 25 | $2.4B | $617.4M | ||
| Q3 25 | $2.4B | $617.2M | ||
| Q2 25 | $2.3B | $617.0M | ||
| Q1 25 | $2.3B | $616.8M | ||
| Q4 24 | $2.4B | $616.6M | ||
| Q3 24 | $2.3B | $616.4M | ||
| Q2 24 | $2.7B | $1.1B | ||
| Q1 24 | $2.7B | $1.1B |
| Q4 25 | $2.4B | $6.0B | ||
| Q3 25 | $2.4B | $5.8B | ||
| Q2 25 | $2.3B | $5.6B | ||
| Q1 25 | $2.2B | $5.5B | ||
| Q4 24 | $2.1B | $5.7B | ||
| Q3 24 | $2.0B | $5.6B | ||
| Q2 24 | $1.8B | $5.4B | ||
| Q1 24 | $1.7B | $5.3B |
| Q4 25 | $7.1B | $41.3B | ||
| Q3 25 | $6.9B | $41.7B | ||
| Q2 25 | $6.8B | $39.9B | ||
| Q1 25 | $6.6B | $40.4B | ||
| Q4 24 | $6.5B | $39.9B | ||
| Q3 24 | $6.5B | $38.9B | ||
| Q2 24 | $6.4B | $37.8B | ||
| Q1 24 | $6.2B | $38.3B |
| Q4 25 | 1.00× | 0.10× | ||
| Q3 25 | 1.01× | 0.11× | ||
| Q2 25 | 1.02× | 0.11× | ||
| Q1 25 | 1.08× | 0.11× | ||
| Q4 24 | 1.14× | 0.11× | ||
| Q3 24 | 1.20× | 0.11× | ||
| Q2 24 | 1.46× | 0.21× | ||
| Q1 24 | 1.54× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $382.4M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $369.0M |
| 自由现金流率自由现金流/营收 | 7.6% | 32.7% |
| 资本支出强度资本支出/营收 | 14.8% | 1.2% |
| 现金转化率经营现金流/净利润 | 2.37× | 1.45× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $1.1B |
8季度趋势，按日历期对齐
| Q4 25 | $346.0M | $382.4M | ||
| Q3 25 | $270.8M | $338.3M | ||
| Q2 25 | $270.2M | $607.5M | ||
| Q1 25 | $288.6M | $-211.2M | ||
| Q4 24 | $278.8M | $694.6M | ||
| Q3 24 | $267.8M | $198.3M | ||
| Q2 24 | $217.4M | $207.2M | ||
| Q1 24 | $238.8M | $-609.7M |
| Q4 25 | $116.7M | $369.0M | ||
| Q3 25 | $83.7M | $321.1M | ||
| Q2 25 | $113.3M | $592.7M | ||
| Q1 25 | $125.5M | $-227.8M | ||
| Q4 24 | $80.1M | $677.2M | ||
| Q3 24 | $120.3M | $185.6M | ||
| Q2 24 | $60.5M | $173.3M | ||
| Q1 24 | $99.4M | $-619.4M |
| Q4 25 | 7.6% | 32.7% | ||
| Q3 25 | 5.7% | 33.4% | ||
| Q2 25 | 7.8% | 70.6% | ||
| Q1 25 | 8.6% | -27.0% | ||
| Q4 24 | 5.7% | 73.9% | ||
| Q3 24 | 8.9% | 22.9% | ||
| Q2 24 | 4.6% | 21.7% | ||
| Q1 24 | 7.6% | -80.6% |
| Q4 25 | 14.8% | 1.2% | ||
| Q3 25 | 12.7% | 1.8% | ||
| Q2 25 | 10.8% | 1.8% | ||
| Q1 25 | 11.2% | 2.0% | ||
| Q4 24 | 14.1% | 1.9% | ||
| Q3 24 | 10.9% | 1.6% | ||
| Q2 24 | 12.1% | 4.2% | ||
| Q1 24 | 10.6% | 1.3% |
| Q4 25 | 2.37× | 1.45× | ||
| Q3 25 | 2.14× | 1.60× | ||
| Q2 25 | 1.90× | 3.92× | ||
| Q1 25 | 1.90× | -3.99× | ||
| Q4 24 | 2.31× | 2.85× | ||
| Q3 24 | 2.48× | 1.25× | ||
| Q2 24 | 1.91× | 1.25× | ||
| Q1 24 | 2.12× | -3.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
SF
暂无分部数据
